Document:

ex10_saleemagr.htm

EMPLOYMENT AGREEMENT

 

BETWEEN

 

BCB COMMUNITY BANK AND AMER SALEEM

 

This Employment Agreement (the “Agreement”) is made effective as of the  30th day of July, 2013 (the “Effective Date”), by and between BCB Community Bank, a New Jersey chartered bank (the “Bank”), with its principal offices at Bayonne, New Jersey, and AMER SALEEM (“Executive”). Any reference to the “Company,” shall mean BCB Bancorp, Inc., or any successor thereto.

 

WHEREAS, the Bank wishes to assure itself of the continued services of Executive for the period provided in this Agreement; and

 

WHEREAS, in order to induce Executive to remain in the employ of the Bank and to provide further incentive for Executive to achieve the financial and performance objectives of the Bank, the parties desire to enter into this Agreement; and

 

WHEREAS, the Bank desires to set forth the rights and responsibilities of Executive and the compensation payable to Executive, as modified from time to time.

 

NOW, THEREFORE, in consideration of the mutual covenants herein contained, and upon the other terms and conditions hereinafter provided, the parties hereby agree as follows:

 

	
1.  

	
POSITION AND RESPONSIBILITIES

 

During the term of this Agreement, Executive agrees to serve as Chief Lending Officer of the Bank (the “Executive Position”), and will perform all duties and will have all powers associated with such position as set forth in the Job Description provided to Executive by the Bank and as may be set forth in the Bylaws of the Bank.  The Job Description is attached hereto as Exhibit A. In addition, Executive shall be responsible for establishing the business objectives, policies and strategic plans of the Bank, in conjunction with the
Board of Directors of the Bank (“Board”).  During the term of the Agreement, Executive also agrees to serve, if elected, as an officer and/or director of any subsidiary or affiliate of the Bank and in such capacity carry out such duties and responsibilities reasonably appropriate to that office.

 

2.        TERM AND ANNUAL REVIEW

 

a. Term.  The term of this Agreement will begin as of the Effective Date and will continue for twelve (12) full calendar months thereafter.

 

b.  Annual Review.  On an annual basis, at least thirty (30) and not more than sixty (60) days prior to the end of the term of this Agreement, the compensation committee (the “Committee”) designated by the Board will conduct a comprehensive performance evaluation and review of Executive’s performance, and the results thereof will be included in the Minutes of the Board’s meeting.

 

  

  

  

c.  Continued Employment Following Expiration of Term.  Nothing in this Agreement shall mandate or prohibit a continuation of Executive’s employment following the expiration of the term of this Agreement, upon such terms and conditions as the Bank and Executive may mutually agree.

 

3.           PERFORMANCE OF DUTIES

 

During the period of his employment hereunder, except for periods of absence occasioned by illness, reasonable vacation periods, and reasonable leaves of absence, Executive will devote all of his business time, attention, skill and efforts to the faithful performance of his duties under this Agreement, including activities and duties directed by the Board.  Notwithstanding the preceding sentence, subject to the approval of the Board, Executive may serve as a member of the board of directors of business, community and charitable organizations, provided that in each case such service shall not materially interfere with the performance of his duties under this Agreement, adversely affect the reputation of
the Bank or any other affiliates of the Bank, or present any conflict of interest.  Executive will present annually to the Board for its review and approval, a list of organizations in which Executive is participating or proposes to participate.  Such service to and participation in outside organizations will be presumed for these purposes to be for the benefit of the Bank, and the Bank will reimburse Executive his reasonable expenses associated therewith, to the extent Executive’s expenses are not reimbursed by such organizations.

4.           COMPENSATION AND REIMBURSEMENT

 

a.       Base Salary.  In consideration of Executive’s performance of the responsibilities and duties set forth in Section 1, the Bank will provide Executive the compensation specified in this Agreement.  The Bank will pay Executive a salary of $175,000 for the term of this Agreement (“Base Salary”).  Such Base Salary will be payable in accordance with the customary payroll practices
of the Bank.

 

b.       Bonus and Incentive Compensation.  Executive shall be eligible to receive up to fifty (50%) percent of his Base Salary in a performance bonus for the term of this Agreement. Payment of a performance bonus, if applicable, shall be made no later March 15 of the calendar year immediately following the year in which the performance bonus was earned.  In addition, Executive may be entitled to participate in any other incentive compensation and bonus plans or arrangements of the Bank or the Company.  Any
incentive compensation will be paid in cash in accordance with the terms of such plans or arrangements, or on a discretionary basis by the Committee.  Nothing paid to Executive under any such plans or arrangements will be deemed to be in lieu of other compensation to which Executive is entitled under this Agreement.

 

c.       Benefit Plans.  Executive will be entitled to participate in all employee benefit plans, arrangements and perquisites offered to employees and executives of the Company or the Bank.  Without limiting the generality of the foregoing provisions of this Section 4(c), Executive also will be entitled to participate in any employee benefit plans including but not limited to, stock benefit plans, retirement plans, supplemental retirement plans, pension plans, profit-sharing plans, health-and-accident plans, or any
other employee benefit plan or arrangement made available by the Bank in the future to its senior executives and key management employees, subject to and on a basis consistent with the terms, conditions and overall administration of such plans and arrangements.

 

  

2

  

d.       Health, Dental, Life and Disability Coverage.  The Bank shall provide Executive with life, medical, dental and disability coverage made available by the Bank to its senior executives and key management employees, subject to and on a basis consistent with the terms, conditions and overall administration of such coverage.

 

e.       Vacation and Leave.  Executive will be entitled to paid vacation time each year during the term of this Agreement measured on a fiscal or calendar year basis, in accordance with the Bank’s customary practices, as well as sick leave, holidays and other paid absences in accordance with the Bank’s policies and procedures for senior executives.  Any unused paid time off during an annual period will be treated in accordance with the Bank’s personnel policies as in effect from time to
time.

 

f.    Expense Reimbursements.  The Bank will reimburse Executive for all reasonable travel, entertainment and other reasonable expenses incurred by Executive during the course of performing his obligations under this Agreement, including, without limitation, fees for memberships in such organizations as Executive and the Board mutually agree are necessary and appropriate in connection with the performance of his duties under this Agreement, upon substantiation of such expenses in accordance with
applicable policies and procedures of the Bank.  All reimbursements pursuant to this Section 4(f) shall be paid promptly by the Bank and in any event no later than March 15 of the year immediately following the year in which the expense was incurred.   

5.           WORKING FACILITIES

 

Executive’s principal place of employment will be at such place as directed by the Board.  The Bank will provide Executive at his principal place of employment with a private office, secretarial and other support services and facilities suitable to his position with the Bank and necessary or appropriate in connection with the performance of his duties under this Agreement.

 

6.           TERMINATION AND TERMINATION PAY

 

Subject to Section 7 of this Agreement which governs the occurrence of a Change in Control, Executive’s employment under this Agreement may be terminated in the following circumstances:

 

a.       Death.  Executive’s employment under this Agreement will terminate upon his death during the term of this Agreement, in which event Executive’s estate or beneficiary will receive the compensation due to Executive through the last day of the calendar month in which his death occurred, and the Bank will continue to provide to Executive’s family, for one (1) year after Executive’s death, non-taxable medical and dental coverage substantially comparable (and on substantially the same terms and
conditions) to the coverage maintained by the Bank for Executive and his family immediately prior to Executive’s death.

 

b.       Retirement.  This Agreement will terminate upon Executive’s “Retirement” under the retirement benefit plan or plans of the Bank in which he participates.  Executive will not be entitled to the termination benefits specified in Section 6 or 7 hereof in the event of termination due to Retirement.  For purposes of this Agreement, termination of Executive’s employment based on Retirement shall include termination of Executive’s employment by the Board for any reason after
Executive attains the age of sixty-five (65) or in accordance with any retirement arrangement established by the Board with Executive’s consent.

 

  

3

  

c.           Disability.

 

	
(i)  

	
Termination of Executive’s employment based on “Disability” shall mean termination because of any permanent and totally physical or mental impairment that restricts Executive from performing all the essential functions of normal employment.  A determination as to whether Executive has suffered a Disability shall be made by the Board with objective medical input.  In the event of termination due to Disability, Executive will be entitled to disability benefits, if any, provided under a long term disability plan sponsored by the Bank, if any.

 

	
(ii)  

	
In the event the Board determines that Executive is Disabled, Executive will no longer be obligated to perform services under this Agreement.  Upon Executive’s termination due to Disability, the Bank will cause to continue to provide to Executive life insurance and non-taxable medical and dental coverage substantially comparable (and on substantially the same terms and conditions) to the coverage maintained by the Company or the Bank for Executive immediately prior to his termination for Disability.  This coverage shall cease upon the earlier of (i) three (3) years from the date of termination, or (ii) the date Executive becomes eligible for Medicare coverage; provided further that if Executive is
covered by family coverage or coverage for self and spouse, then Executive’s family or spouse shall continue to be covered for the remainder of the three (3) year period, or in the case of the spouse, until the spouse becomes eligible for Medicare coverage or obtains health care coverage elsewhere, whichever period is less.

 

d.           Termination for Cause.

 

(i)          The Board may by written notice to Executive in the form and manner specified in this paragraph, immediately terminate his employment at any time for “Cause.”  Executive shall have no right to receive compensation or other benefits for any period after termination for Cause, except for already vested benefits.  Termination for Cause shall mean termination because of, in the good faith determination of the Board, Executive’s:

 

	
(1)  

	
material act of dishonesty in performing Executive’s duties on behalf of the Bank;

 

  

4

  

	
(2)  

	
willful misconduct that in the judgment of the Board will likely cause economic damage to the Bank or injury to the business reputation of the Bank;

 

	
(3)  

	
incompetence (in determining incompetence, the acts or omissions shall be measured against standards generally prevailing in the commercial banking  industry);

 

	
(4)  

	
breach of fiduciary duty involving personal profit;

 

	
(5)  

	
intentional failure to perform stated duties under this Agreement after written notice thereof from the Board;

 

	
(6)  

	
willful violation of any law, rule or regulation (other than traffic violations or similar offenses) that reflect adversely on the reputation of the Bank, any felony conviction, any violation of law involving moral turpitude, or any violation of a final cease-and-desist order;

 

	
(7)  

	
material breach by Executive of any provision of this Agreement; or,

 

	
(8)  

	
failure to satisfy the requirements set forth in the Executive’s Job Description.

 

(ii)                      Notwithstanding the foregoing, prior to a Change in Control, as that term is defined hereafter, Executive’s termination for Cause will not become effective unless the Board has delivered to Executive a copy of a notice of termination in accordance with Section 8(a) hereof.  Following a Change in Control, Executive shall not be deemed to have beenterminated for Cause unless and until there shall have been delivered to him a notice of termination which shall include a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the
disinterested members of the Board that Executive was guilty of the conduct described above andspecifying the particulars of such conduct.

 

e.           Voluntary Termination by Executive.  In addition to his other rights to terminate his employment under this Agreement, Executive may voluntarily terminate employment during the term of this Agreement upon at least sixty (60) days prior written notice to the Board.  Upon Executive’s voluntary termination, he will receive only his compensation and vested rights and benefits to the date of his termination.  Following his voluntary termination of employment under this Section
6(e), Executive will be subject to the restrictions set forth in Sections 9(a) and 9(b) of this Agreement.

 

  

5

  

 

f.           Termination Without Cause or With Good Reason.

 

(i)           The Board may, by written notice to Executive, immediately terminate his employment at any time for a reason other than Cause (a termination “Without Cause”), and Executive may, by written notice to the Board, terminate this Agreement at any time within ninety (90) days following an event constituting “Good Reason,” as defined below (a termination “With Good Reason”); provided, however, that the Bank shall have thirty (30) days to cure the “Good Reason” condition, but the Bank may waive its right to cure.  Any termination of Executive’s
employment, other than Termination for Cause, shall have no effect on or prejudice the vested rights of Executive under the Bank’s qualified or non-qualified retirement, pension, savings, thrift, profit-sharing or stock bonus plans, group life, health (including hospitalization, medical and major medical), dental, accident and long term disability insurance plans or other employee benefit plans or programs, or compensation plans or programs in which Executive was a participant.

 

(ii)           In the event of termination under this Section 6(f), the Bank shall pay Executive, or in the event of Executive’s subsequent death, Executive’s beneficiary or estate, as the case may be, as severance pay, a cash lump sum payment equal to his Base Salary. Such payment shall be payable within thirty (30) days following Executive’s date of termination, and will be subject to applicable withholding taxes.

 

	
(iii)  

	
In addition, the Bank will continue to provide to Executive, life insurance coverage and non-taxable medical and dental insurance coverage substantially comparable (and on substantially the same terms and conditions) to the coverage maintained by the Bank for Executive immediately prior to his termination.  Such life insurance coverage and non-taxable medical and dental insurance coverage shall cease upon the earlier of (i) the end of the term of this Agreement, or (ii) with respect to each such coverage (e.g., life insurance, medical and/or dental coverage), the date on which such coverage is made available to the Executive through subsequent employment.

 

	
(iv)  

	
“Good Reason” exists if, without Executive’s express written consent, any of the following occurs:

 

	
(1)  

	
a failure to elect or reelect or to appoint or reappoint Executive to the Executive Position held on the Effective Date of this Agreement;

 

  

6

  

	
(2)  

	
a material change in Executive’s position to become one of lesser responsibility, importance, or scope from the position and attributes thereof described in Section 1 above;

 

	
(3)  

	
a liquidation or dissolution of the Bank other than liquidations or dissolutions that are caused by reorganizations that do not negatively affect the status of Executive;

 

	
(4)  

	
a material reduction or elimination of Executive’s benefits under one or more benefit plans maintained by the Bank as part of a good faith, overall reduction or elimination of such plans or benefits applicable to all participants in a manner that does not discriminate against Executive (except as such discrimination may be necessary to comply with applicable law); or,

 

	
(5)  

	
a material breach of this Agreement by the Bank.

 

g.           Termination and Board Membership.  To the extent Executive is a member of the board of directors of the Company, the Bank or any of their affiliates on the date of termination of employment with the Bank (other than a termination due to Retirement), Executive will resign from all of the boards of directors immediately following such termination of employment with the Bank.  Executive will be obligated to tender this resignation regardless of the method or manner of termination (other than
termination due to Retirement), and such resignation will not be conditioned upon any event or payment.

 

7.           CHANGE IN CONTROL

 

a.           Change in Control Defined.  For purposes of this Agreement, a “Change in Control” shall mean a change in the effective control of the Company or Bank, as described below.

 

(i)           A change in the effective control of the Company or Bank occurs on the date that (i) any one person, or more than one person acting as a group (as defined in Treasury Regulation 1.409A-3(i)(5)(vi)(D)) acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company or Bank possessing more than 50 percent of the total voting power of the stock of the Company or Bank, and (ii) a majority of the members of the Company’s or Bank’s board of directors is replaced during any 12-month period by
directors whose appointment or election is not endorsed by a majority of the members of the Company’s or Bank’s board of directors prior to the date of the appointment or election.

 

b.           Change In Control Benefits.  Upon the occurrence of a Change in Control, the Bank shall pay Executive a lump-sum cash payment equal to three (3) times the sum of the average annualized Base Salary paid to Executive during the three (3) years prior to the Change in Control or such fewer number of years Executive has been employed with the Bank. Such payment shall be payable within thirty (30) days following the date of the Change in Control, and will be
subject to all applicable withholding taxes.  Notwithstanding the foregoing, the cash payment made pursuant to this Section 7(b) shall be made in lieu of any cash payments that are subsequently triggered pursuant to Section 6(f)(ii) hereof.

 

  

7

  

c.           280G Cutback.  Notwithstanding anything in this Agreement to the contrary, in no event shall the aggregate payments or benefits to be made or afforded to Executive under this Agreement, either as a stand-alone benefit or when aggregated with other payments to, or for the benefit of, Executive that are contingent on a Change in Control, constitute an “excess parachute payment” under Section 280G of the Internal Revenue Code
(“Code”) or any successor thereto, and in order to avoid such a result, Executive’s benefits hereunder shall be reduced, if necessary, to an amount, the value of which is one dollar ($1.00) less than an amount equal to three (3) times Executive’s “base amount,” as determined in accordance with Code Section 280G.  In the event a reduction is necessary, the cash severance payable pursuant to this Section 7 hereof shall be reduced by the minimum amount necessary to result in no portion of the payments and benefits payable by the Bank under this Section 7 being non-deductible pursuant to Code Section 280G and subject to excise tax imposed under Code Section 4999.

 

           8.           NOTICE

 

a.           Notice of Termination.  A “notice of termination” shall mean a written notice which shall indicate the specific termination provision in this Agreement relied upon as a basis for termination of Executive’s employment.

 

b.           Date of Termination.  “Date of termination” shall mean (i) if Executive’s employment is terminated for Disability, thirty (30) days after a notice of termination is given (provided that he shall not have returned to the performance of his duties on a full-time basis during such thirty (30) day period), (ii) if Executive terminates employment With Good Reason, thirty (30) days after a notice of termination is given, or (iii) if Executive’s employment is terminated for any
other reason, the date specified in the notice of termination.

 

c.           Good Faith Resolution.  If the party receiving a notice of termination desires to dispute or contest the basis or reasons for termination, the party receiving the notice of termination must notify the other party within twenty (20) days after receiving the notice of termination that such a dispute exists, and shall pursue the resolution of such dispute in good faith and with reasonable diligence pursuant to Section 17 of this Agreement.  During the twenty (20) days after receiving notice
of termination and during the pendency of any such dispute, the Bank shall not be obligated to pay Executive compensation or other payments beyond the date of termination.  Any amounts paid to Executive upon resolution of such dispute under this Section shall be offset against or reduce any other amounts due under this Agreement.

 

           9.           POST-TERMINATION OBLIGATIONS/NON-COMPETE

 

a.           Non-Solicitation/Non-Compete.  Executive hereby covenants and agrees that, for a period of one (1) year following his termination of employment with Bank (other than a termination of employment following a Change in Control), he shall not, without the written consent of Bank, either directly or indirectly:

 

  

8

  

(i)           solicit, offer employment to, or take any other action intended (or that a reasonable person acting in like circumstances would expect) to have the effect of causing any officer or employee of the Bank, or any of its respective subsidiaries or affiliates, to terminate his employment and accept employment or become affiliated with, or provide services for compensation in any capacity whatsoever to, any business whatsoever that competes with the business of the Bank, or any of their direct or indirect subsidiaries or affiliates, that has headquarters or offices within twenty-five (25) miles of any
location(s) in which the Bank has business operations or has filed an application for regulatory    approval to establish an office;

 

(ii)           become an officer, employee, consultant, director, independent contractor, agent, joint venturer, partner or trustee of any savings bank, savings and loan association, savings and loan holding company, credit union, bank or bank holding company, insurance company or agency, any mortgage or loan broker or any other entity that competes with the business of the Bankor any of their direct or
indirect subsidiaries or affiliates, that: (i) has a headquarters within twenty-five (25) miles of any location(s) in which the Bank has business operations or has filed an application for regulatory approval to establish an office (the “Restricted Territory”) or (ii) has one or more offices, but is not headquartered, within the Restricted Territory, but in the latter case, only if Executive would be employed, conduct business or have other responsibilities or duties within the Restricted Territory; or

 

(iii)           solicit, provide any information, advice or recommendation or take any other action intended (or that a reasonable person acting in like circumstances would expect) to have the effect of causing any customer of the Bank to terminate an existing business or commercial relationship with the Bank.

 

b.           Confidentiality.  Executive recognizes and acknowledges that the knowledge of the business activities, plans for business activities, and all other proprietary information of the Bank, as it may exist from time to time, are valuable, special and unique assets of the business of the Bank.  Executive will not, during or after the term of his employment, disclose any knowledge of the past, present, planned or considered business activities or any other similar proprietary information of the
Bank to any person, firm, corporation, or other entity for any reason or purpose whatsoever unless expressly authorized by the Board or required by law.  Notwithstanding the foregoing, Executive may disclose any knowledge of banking, financial and/or economic principles, concepts or ideas which are not solely and exclusively derived from the business plans and activities of the Bank.  Further, Executive may disclose information regarding the business activities of the Bank to any bank regulator having regulatory jurisdiction over the activities of the Bank pursuant to a formal regulatory request.  In the event of a breach or threatened breach by Executive of the provisions of this Section, the Bank will be entitled to an injunction restraining Executive from disclosing, in whole or in part, the knowledge of the past, present, planned or considered business
activities of the Bank or any other similar proprietary information, or from rendering any services to any person, firm, corporation, or other entity to whom such knowledge, in whole or in part, has been disclosed or is threatened to be disclosed.  Nothing herein will be construed as prohibiting the Bank from pursuing any other remedies available to the Bank for such breach or threatened breach, including the recovery of damages from Executive.

 

  

9

  

c.           Information/Cooperation.  Executive shall, upon reasonable notice, furnish such information and assistance to the Bank as may be reasonably required by the Bank, in connection with any litigation in which it or any of its subsidiaries or affiliates is, or may become, a party; provided, however, that Executive shall not be required to provide information or assistance with respect to any litigation between Executive and the Bank or any other subsidiaries or affiliates.

 

d.           Reliance.  All payments and benefits to Executive under this Agreement shall be subject to Executive’s compliance with this Section 9, to the extent applicable.  The parties hereto, recognizing that irreparable injury will result to the Bank, its business and property in the event of Executive’s breach of this Section 9, agree that, in the event of any such breach by Executive, the Bank will be entitled, in addition to any other remedies and damages available, to an injunction
to restrain the violation hereof by Executive and all persons acting for or with Executive. Executive represents and admits that Executive’s experience and capabilities are such that Executive can obtain employment in a business engaged in other lines of business than the Bank, and that the enforcement of a remedy by way of injunction will not prevent Executive from earning a livelihood.  Nothing herein will be construed as prohibiting the Bank from pursuing any other remedies available to them for such breach or threatened breach, including the recovery of damages from Executive.

 

10.           SOURCE OF PAYMENTS/RELEASE

 

a.           All payments provided in this Agreement shall be timely paid in cash or check from the general funds of the Bank.

 

b.           Notwithstanding anything to the contrary in this Agreement, Executive shall not be entitled to any payments or benefits under Section 6 of this Agreement unless and until Executive executes an unconditional release of any claims against the Company, the Bank, and their affiliates, including their officers, directors, successors and assigns, releasing said persons from any and all claims, rights, demands, causes of action, suits, arbitrations or grievances relating to the employment relationship other than claims for benefits under tax-qualified plans or other benefit plans in which Executive
is vested, claims for benefits required by applicable law or claims with respect to obligations set forth in this Agreement that survive the termination of this Agreement.

 

  

10

  

11.           REQUIRED REGULATORY PROVISIONS

 

a.           Notwithstanding anything herein contained to the contrary, any payments to Executive by the Bank, whether pursuant to this Agreement or otherwise, are subject to and conditioned upon their compliance with Section 18(k) of the Federal Deposit Insurance Act, 12 U.S.C. Section 1828(k), and the regulations promulgated thereunder in 12 C.F.R. Part 359.

 

b.           Notwithstanding anything else in this Agreement to the contrary, Executive’s employment shall not be deemed to have been terminated unless and until Executive has a Separation from Service within the meaning of Code Section 409A.  For purposes of this Agreement, a “Separation from Service” shall have occurred if the Bank and Executive reasonably anticipate that either no further services will be performed by Executive after the date of the termination (whether as an employee or as an independent contractor) or the
level of further services performed is less than 50% of the average level of bona fide services in the thirty-six (36) months immediately preceding the termination.  For all purposes hereunder, the definition of Separation from Service shall be interpreted consistent with Treasury Regulation Section 1.409A-1(h)(ii).

 

c.           Notwithstanding the foregoing, in the event the Executive is a Specified Employee (as defined herein), then, solely, to the extent required to avoid penalties under Code Section 409A, the Executive’s payments shall be delayed until the first day of the seventh month following the Executive’s Separation from Service.  A “Specified Employee” shall be interpreted to comply with Code Section 409A and shall mean a key employee within the meaning of Code Section 416(i) (without regard to paragraph 5 thereof), but an
individual shall be a “Specified Employee” only if the Bank or Company is or becomes a publicly traded company.

 

12.           NO ATTACHMENT

 

Except as required by law, no right to receive payments under this Agreement shall be subject to anticipation, commutation, alienation, sale, assignment, encumbrance, charge, pledge, or hypothecation, or to execution, attachment, levy, or similar process or assignment by operation of law, and any attempt, voluntary or involuntary, to effect any such action shall be null, void, and of no effect.

 

13.           ENTIRE AGREEMENT; MODIFICATION AND WAIVER

 

a.           This Agreement contains the entire agreement of the parties relating to the subject matter hereof, and supersedes in its entirety any and all prior agreements, understandings or representations relating to the subject matter hereof, except that the parties acknowledge that this Agreement shall not affect any of the rights and obligations of the parties  under any agreement or plan entered into with or by the Bank pursuant to which Executive may receive compensation or benefits except as set forth in Section 6(d) hereof.

 

b.           This Agreement may not be modified or amended except by an instrument in writing signed by each of the parties hereto.

 

  

11

  

c.           No term or condition of this Agreement shall be deemed to have been waived, nor shall there be any estoppel against the enforcement of any provision of this Agreement, except by written instrument of the party charged with such waiver or estoppel.  No such written waiver shall be deemed a continuing waiver unless specifically stated therein, and each such waiver shall operate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future as to any act other than that specifically waived.

 

	
14.

	
SEVERABILITY

 

If, for any reason, any provision of this Agreement, or any part of any provision, is held invalid, such invalidity shall not affect any other provision of this Agreement or any part of such provision not held so invalid, and each such other provision and part thereof shall to the full extent consistent with law continue in full force and effect.

 

15.           HEADINGS FOR REFERENCE ONLY

 

The headings of sections and paragraphs herein are included solely for convenience of reference and shall not control the meaning or interpretation of any of the provisions of this Agreement.

 

16.           GOVERNING LAW

 

This Agreement shall be governed by the laws of the State of New Jersey, but only to the extent not superseded by federal law.

 

17.           ARBITRATION

 

Any dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by binding arbitration, as an alternative to civil litigation and without any trial by jury to resolve such claims, conducted by a single arbitrator mutually acceptable to the Bank and Executive, sitting in a location selected by the Bank within twenty-five (25) miles from the main office of the Bank, in accordance with the rules of the American Arbitration Association’s National Rules for the Resolution of Employment Disputes then in effect.  Judgment may be entered on the arbitrator’s award in any court having
jurisdiction.

 

18.           INDEMNIFICATION

 

Insurance.  During the term of this Agreement, the Bank will provide Executive with coverage under a directors’ and officers’ liability policy at the Bank’s expense, that is at least equivalent to the coverage provided to directors and senior executives of the Bank.

 

  

12

  

19.           SUCCESSORS AND ASSIGNS

 

The Bank shall require any successor or assignee, whether direct or indirect, by purchase, merger, consolidation or otherwise, to all or substantially all the business or assets of the Bank, expressly and unconditionally to assume and agree to perform the Bank’s obligations under this Agreement, in the same manner and to the same extent that the Bank would be required to perform if no such succession or assignment had taken place.

 

[Signature Page to Follow]

  

13

  

SIGNATURES

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement on the dates set forth below.

 

	  	
BCB COMMUNITY BANK

	  	  
	  	  
	
August 13, 2013

	
By:           /s/ Mark Hogan

	  	
Name:           Mark Hogan

	  	
Title:           Chairman of the Board

 

 

	  	
EXECUTIVE

	  	  
	  	  
	
August 13, 2013

	
By:           /s/ Amer Saleem

	  	
Amer Saleem

	  	  

 

  

14

  

BCB COMMUNUITY BANK

 

Job Description Summary

 

CHIEF LENDING OFFICER

 

 

Position Summary

 

Directs and coordinates all lending activities within the Bank.  Participates in strategic planning and the development of the Bank’s lending policies, procedures and goals.  Responsible for the Bank’s administrative management of loan functions.  Develops and implements consistent organizational policies and procedures.  Directs and monitors all lending operations, including commercial loans and consumer loans.

 

 

Key Areas of Responsibility

 

 

	
·  

	
Communicates professionally with all employees to ensure positive and clear understanding of the Bank’s goals and direction.  Demonstrates effective leadership skills, creating a positive environment where employees thrive and the organization achieves desired results.

 

	
·  

	
Participates in the Bank’s long and short term strategic planning.

 

	
·  

	
Selects and provides for the continuing development of subordinate managers and staff.  Conducts periodic performance reviews and provides ongoing guidance, training and direction to managers in developing and implementing the Bank’s plans and objectives.  Promotes cost consciousness and fiscal responsibility.

 

	
·  

	
Attends Loan Committee and Board of Directors meetings.  Submits recommendations for approval.

 

	
·  

	
Sets loan rates in conjunction with the Executive Management.  Develops and Introduces new loan products.  Monitors economic and competitive changes in the market place.

 

	
·  

	
Reviews commercial credits, credit risk and approved loans.  Coordinates third party loan review process.  Review and approves loans for reclassification.

 

	
·  

	
Keeps abreast of ongoing developments in the field of lending.  Attends relevant seminars and training programs.

 

	
·  

	
Interacts with Bank regulators, accountants, auditors and loan review representatives.

 

	
·  

	
Ensures that the loan production budget is achieved in the most prudent and efficient manner to safeguard the assets of the institution.

 

	
·  

	
Insure that Asset Quality is rated a “2” or better on the Bank’s annual safety and soundness exam.

	
·  

	
Identify Loan portfolio risk for the Loan Committee.

	
·  

	
Identify opportunities for the Bank to lead in our lending market.EX-4.02

 Exhibit 4.02 
 CHEGG, INC. 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT

 March 7, 2012 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
			
	1.	 	 Registration Rights
	  	 	2	  
	 1.1.
	 	 Definitions
	  	 	2	  
	 1.2.
	 	 Request for Registration
	  	 	3	  
	 1.3.
	 	 Company Registration
	  	 	5	  
	 1.4.
	 	 Obligations of the Company
	  	 	5	  
	 1.5.
	 	 Furnish Information
	  	 	7	  
	 1.6.
	 	 Expenses of Demand Registration
	  	 	7	  
	 1.7.
	 	 Expenses of Company Registration
	  	 	7	  
	 1.8.
	 	 Underwriting Requirements
	  	 	7	  
	 1.9.
	 	 Delay of Registration
	  	 	8	  
	 1.10.
	 	 Indemnification
	  	 	8	  
	 1.11.
	 	 Reports Under Securities Exchange Act
	  	 	11	  
	 1.12.
	 	 Form S-3 Registration
	  	 	11	  
	 1.13.
	 	 Transfer or Assignment of Registration Rights
	  	 	14	  
	 1.14.
	 	 Limitations on Subsequent Registration Rights
	  	 	14	  
	 1.15.
	 	 “Market Stand-Off” Agreement
	  	 	14	  
	 1.16.
	 	 Termination of Registration Rights
	  	 	15	  
			
	2.	 	 Covenants of the Company to the Investors
	  	 	15	  
	 2.1.
	 	 Information Rights
	  	 	15	  
	 2.2.
	 	 Visitation and Inspection
	  	 	16	  
	 2.3.
	 	 Right of First Offer
	  	 	16	  
	 2.4.
	 	 Other Covenants
	  	 	18	  
	 2.5.
	 	 Observer Rights
	  	 	19	  
	 2.6.
	 	 Confidentiality, Assignment and Termination of Covenants
	  	 	19	  
			
	3.	 	 Investment Activities
	  	 	20	  
			
	4.	 	 Legend
	  	 	21	  
			
	5.	 	 Miscellaneous
	  	 	21	  
	 5.1.
	 	 Governing Law
	  	 	21	  
	 5.2.
	 	 Waiver of Right of First Offer
	  	 	21	  
	 5.3.
	 	 Waivers and Amendments
	  	 	21	  
	 5.4.
	 	 Successors and Assigns
	  	 	22	  
	 5.5.
	 	 Entire Agreement
	  	 	22	  
	 5.6.
	 	 Notices
	  	 	22	  
	 5.7.
	 	 Interpretation
	  	 	22	  
	 5.8.
	 	 Severability
	  	 	23	  
	 5.9.
	 	 Aggregation of Stock
	  	 	23	  
	 5.10.
	 	 Counterparts
	  	 	23	  
	 5.11.
	 	 Telecopy Execution and Delivery
	  	 	23	  
	 5.12.
	 	 Delay or Omission
	  	 	23	  

  
 i 

							
	 5.13.
	 	 Specific Performance
	  	 	24	  
	 5.14.
	 	 Termination of Series E Rights Agreement
	  	 	24	  

 SCHEDULES: 
 A      -        Schedule of Investors 

  
 ii 

 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of March 7, 2012, by and
among CHEGG, INC., a Delaware corporation (the “Company”), and the individuals and entities listed on SCHEDULE A hereto (each, an “Investor” and collectively, the “Investors”),
and is effective contingent and immediately upon the Closing (as defined in the Series F Agreement (as defined below)) (the “Effective Date”). 
 RECITALS 
 WHEREAS, certain Investors hold (i) shares of the
Company’s Series A Preferred Stock and/or shares of Common Stock issued upon conversion thereof (the “Series A Stock”) pursuant to the Series A Preferred Stock Purchase Agreement, dated as of August 22,
2005, as amended from time to time, (ii) shares of the Company’s Series A-1 Preferred Stock and/or shares of Common Stock issued upon conversion thereof (the “Series A-1 Stock”) pursuant to the Series A-1
Preferred Stock Purchase Agreement, dated as of September 6, 2006, as amended from time to time, (iii) shares of the Company’s Series B Preferred Stock and/or shares of Common Stock issued upon conversion thereof (the
“Series B Stock”) pursuant to the Series B Preferred Stock Purchase Agreement, dated as of June 11, 2008, (iv) shares of the Company’s Series C-1 Preferred Stock and/or shares of Common Stock issued
upon conversion thereof (the “Series C-1 Stock”) and Series C-2 Preferred Stock and/or shares of Common Stock issued upon conversion thereof (the “Series C-2 Stock” and, together with the
Series C-1 Stock, the “Series C Stock”) pursuant to the Series C Preferred Stock Purchase, dated as of December 9, 2008, (v) shares of the Company’s Series D Preferred Stock and/or shares of Common
Stock issued upon conversion thereof (the “Series D Stock”) pursuant to the Series D Preferred Stock Purchase Agreement, dated as of November 18, 2009, and/or (vi) shares of the Company’s Series E
Preferred Stock and/or shares of Common Stock issued upon conversion thereof (the “Series E Stock”) pursuant to the Series E Preferred Stock Purchase Agreement, dated as of August 18, 2010, and possess registration
rights, information rights, rights of the first refusal and other rights pursuant to that certain Amended and Restated Investors’ Rights Agreement, dated as of August 18, 2010, by and among the Company and such Investors (the
“Series E Rights Agreement”); and 
 WHEREAS, the undersigned Investors who hold Series A
Stock, Series A-1 Stock, Series B Stock, Series C Stock, Series D Stock and/or Series E Stock (the “Prior Investors”) desire to terminate the Series E Rights Agreement and to accept the rights created
pursuant hereto in lieu of the rights granted to them under the Series E Rights Agreement; and 
 WHEREAS, certain
Investors have agreed to purchase from the Company, and the Company has agreed to sell to such Investors, the Company’s Series F Preferred Stock (together with the shares of Common Stock issued upon conversion thereof, the
“Series F Stock”), such purchase being on the terms and conditions contained in the Series F Preferred Stock Purchase Agreement of even date herewith by and among the Company and such Investors, as the same may be amended
from time to time in accordance with its terms (the “Series F Agreement”): 

 NOW, THEREFORE, in consideration of the mutual promises and covenants set forth
herein, the Company and Prior Investors hereby agree that the Series E Rights Agreement shall be superseded and replaced in its entirety by this Agreement, and the parties hereto further agree as follows: 

1. Registration Rights. 
 1.1. Definitions. As used in this Agreement, the following terms shall have the meanings set forth below: 
 (a) “Commission” means the United States Securities and Exchange Commission. 
 (b) “Common Stock” means the Company’s common stock, $0.001 par value per share. 
 (c) “Conversion Stock” means the shares of Common Stock issued or issuable upon conversion of the Shares. 
 (d) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 (e) “Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the Commission that
permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the Commission. 
 (f) “Holder” means any person owning or having the right to acquire Registrable Securities or any assignee thereof in accordance with Section 1.13. 

(g) “Preferred Stock” means the Company’s preferred stock, $0.001 par value per share. 

(h) The terms “register,” “registered” and “registration” refer to a registration
effected by preparing and filing a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document. 

(i) “Registrable Securities” means (i) the Conversion Stock, (ii) any other shares of Common Stock held by the
Holders, and (iii) any of the Company’s Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for, or
in replacement of, the shares referenced in (i) and (ii) above; provided, however, that Registrable Securities shall not include any shares of Common Stock which have previously been registered or which have been sold to the public either
pursuant to a registration statement or Rule 144, or which have been sold in a private transaction in which the transferor’s rights under this Section 1 are not assigned. 

  
 2 

 (j) “Rule 144” means Rule 144 as promulgated by the Commission
under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission. 
 (k) “Rule 145” means Rule 145 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that
may be promulgated by the Commission. 
 (l) “Securities Act” means the Securities Act of 1933, as amended.

 (m) “Shares” means the shares of the Series A Stock, Series A-1 Stock, Series B Stock,
Series C Stock, Series D Stock, Series E Stock and Series F Stock. 
 1.2. Request for Registration.

 (a) Subject to the conditions of this Section 1.2, if the Company shall receive at any time after the earlier of
(i) December 9, 2013 or (ii) one hundred eighty (180) days after the effective date of the first registration statement for a public offering of securities of the Company (other than a registration statement relating solely to
employee benefit or similar plans or a registration statement relating to a Rule 145 transaction), a written request from the Holders of at least forty percent (40%) of the Registrable Securities then outstanding that the Company effect a
registration under the Securities Act with respect to at least a majority of the Registrable Securities then outstanding and having aggregate proceeds (net of underwriting discounts and commissions) in excess $10,000,000, then the Company shall
(i) give written notice of such request to all Holders within ten (10) calendar days of the date such request is given and (ii) use its best efforts to effect as soon as practicable (and in any event within sixty (60) calendar
days of the date such request is given) the registration under the Securities Act of all Registrable Securities that the Holders request to be registered within twenty (20) calendar days of the date the Company’s notice referred to in this
subsection 1.2(a) is given. 
 (b) If the Holders initiating the registration request hereunder (the “Initiating
Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to subsection 1.2(a) and the Company shall
include such information in the written notice referred to in subsection 1.2(a). The underwriter will be selected by the Company and shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any
Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to
the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in subsection 1.4(e)) enter into an underwriting agreement in customary form with the underwriter
or underwriters selected for such underwriting. Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Initiating Holders in writing that marketing factors require a limitation of the number of shares to be
underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall
be allocated among all Holders electing to include shares in 

  
 3 

 
the underwriting, including the Initiating Holders, in proportion (as nearly as practicable) to the amount of Registrable Securities requested by each such Holder to be included in such
underwriting; provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other securities (including those to be sold for the Company’s account) are first entirely
excluded from the underwriting. For purposes of the preceding parenthetical concerning apportionment, for any selling stockholder which is a Holder of Registrable Securities and which is a partnership, limited liability company or corporation, the
partners (or retired partners), members (or retired members) and stockholders of such selling stockholder, or the estates and family members of any such partners (retired partners), members (or retired members) or stockholders and any trusts for the
benefit of any of the foregoing persons shall be deemed to be a single “selling stockholder” and any pro rata reduction with respect to such “selling stockholder” shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such “selling stockholder” as defined in this sentence. 
 (c) Notwithstanding the foregoing, if the Company shall furnish to the Holders requesting a registration pursuant to this Section 1.2, a certificate signed by the Company’s President stating
that in the good faith judgment of the Company’s Board of Directors, such registration would be seriously detrimental to the Company and its stockholders and that it is, therefore, essential to defer taking action with respect to such
registration, the Company shall have the right to defer taking action with respect to such filing for a period of not more than ninety (90) calendar days after the date the request of the Initiating Holders is given; provided, however,
that the Company may not utilize this right or the right set forth in Section 1.12(c) more than once in any twelve (12) month period; and provided, further, that the Company shall not register any securities for the account of
itself or any other stockholder during such ninety (90) day period other than a registration relating solely to employee benefit or similar plans, or a registration relating to a Rule 145 transaction. 

(d) In addition, the Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to this
Section 1.2: 
 (i) after the Company has effected two (2) registrations pursuant to this Section 1.2 and such
registrations have been declared or ordered effective and have remained effective for at least the period of time described in Section 1.4(a); 
 (ii) during the period starting with the date thirty (30) calendar days prior to the Company’s good faith estimate of the date of filing of, and ending on a date ninety (90) calendar days
after the effective date of, any registration statement pertaining to a public offering of securities for the Company’s account; provided that the Company is actively employing its best efforts to cause such registration statement to be
effective; 
 (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately
registered on Form S-3 pursuant to a request made pursuant to Section 1.12; or 
 (iv) in any particular jurisdiction
in which the Company would be required to qualify to do business or to execute a general consent to service of process in 

  
 4 

 
effecting such registration, qualification or compliance unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act. 

1.3. Company Registration. If (but without any obligation to do so) the Company proposes to register any of its stock or other
securities either for its own account or the account of a stockholder or stockholders exercising their respective demand registration rights (other than (i) a registration pursuant to Sections 1.2 or 1.12, (ii) a registration relating
solely to employee benefit or similar plans, (iii) a registration relating to a Rule 145 transaction or (iv) a registration on any form which does not permit secondary sales or does not include substantially the same information as
would be required to be included in a registration statement covering the Registrable Securities), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given within
twenty (20) calendar days of the date such notice is given, the Company shall, subject to the provisions of Section 1.8, include in the registration all of the Registrable Securities that each such Holder has requested to be registered.

 1.4. Obligations of the Company. Whenever required under this Section 1 to effect the registration of any
Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) Prepare and file with the Commission
a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of at least a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) calendar days or any less period of time in the event the distribution described in the registration statement has been completed;
provided, however, that (i) such 120-day period shall be extended for a period of time equal to the period the Holder refrains from selling any securities included in such registration at the request of an underwriter of Common Stock (or
other securities) of the Company and (ii) in the case of any registration statement on Form S-3 covering securities which are intended to be offered on a continuous or delayed basis, such 120-day period shall be extended, if necessary, to
keep the registration statement effective until all such Registrable Securities are sold, provided that Rule 415, or any successor rule under the Securities Act, permits an offering on a continuous or delayed basis, and provided further that
applicable rules under the Securities Act governing the obligation to file a post-effective amendment permit, in lieu of filing a post-effective amendment which (a) includes any prospectus required by Section 10(a)(3) of the
Securities Act or (b) reflects facts or events representing a material or fundamental change in the information set forth in the registration statement, the incorporation by reference of information required to be included in (a) and
(b) above to be contained in periodic reports filed pursuant to Section 13 or 15(d) of the Exchange Act in the registration statement; 
 (b) Prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply
with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement; 

  
 5 

 (c) Furnish to the Holders such numbers of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) Use its best efforts to register and qualify the securities covered by such registration statement under such other securities or
blue sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions; 
 (e) In the event of any underwritten public offering, enter into and
perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter(s) of such offering (each Holder participating in such underwriting shall also enter into and perform its obligations under such
an agreement); 
 (f) Notify each Holder of Registrable Securities covered by such registration statement at any time when a
prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material
fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 

(g) Cause all such Registrable Securities registered pursuant to this Section 1 to be listed on each securities exchange or
nationally recognized quotation system on which similar securities issued by the Company are then listed; 
 (h) Provide a
transfer agent and registrar for all Registrable Securities registered pursuant to this Section 1 and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; and 

(i) Use its best efforts to cause to be furnished, if required by the underwriting agreement executed in connection with the registration
or at the request of the Holders holding a majority of the Registrable Securities proposed to be sold in the offering, on the date that such Registrable Securities are delivered to the underwriters for sale, if such securities are being sold through
underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, (i) an opinion, dated such date, of the counsel representing the
Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable
Securities and (ii) a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in connection with an
underwritten public offering, addressed to the underwriters, if any, and if permitted by applicable accounting standards, to the Holders requesting registration of Registrable Securities. 

  
 6 

 1.5. Furnish Information. 

(a) It shall be a condition precedent to the Company’s obligations to take any action pursuant to this Section 1 with respect
to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding such Holder, the Registrable Securities held by such Holder, and the intended method of disposition of such securities as
shall be required by the Company or the managing underwriters, if any, to effect the registration of such Holder’s Registrable Securities. 
 (b) The Company shall have no obligation with respect to any registration requested pursuant to Section 1.2 or Section 1.12 if, due to the operation of subsection 1.5(a), the number of shares or
the anticipated aggregate offering price of the Registrable Securities to be included in the registration does not equal or exceed the number of shares or the anticipated aggregate offering price required to originally trigger the Company’s
obligation to initiate such registration as specified in Section 1.2(a) or Section 1.12(c)(ii), whichever is applicable. 
 1.6. Expenses of Demand Registration. All expenses (other than underwriting discounts and commissions) incurred in connection with registrations, filings or qualifications pursuant to
Section 1.2, including (without limitation) all registration, filing and qualification fees, printer’s fees, accounting fees and fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for
the selling Holders shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 1.2 if the registration request is subsequently
withdrawn at the request of the Holders of at least a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses on a pro rata basis based on the number of Registrable Securities
requested to be registered by each Holder), unless the Holders of at least a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 1.2; provided further, however, that if at
the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable
promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one demand registration pursuant to Section 1.2. 

1.7. Expenses of Company Registration. The Company shall bear and pay all expenses incurred in connection with any registration,
filing or qualification of Registrable Securities with respect to the registrations pursuant to Section 1.3 for each Holder, including (without limitation) all registration, filing and qualification fees, printer’s fees, accounting fees
and fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holders, but excluding underwriting discounts and commissions relating to Registrable Securities which shall be borne by
the selling Holders on a pro rata basis based on the number of Registrable Securities sold by each Holder. 
 1.8.
Underwriting Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under 

  
 7 

 
Section 1.3 to include any of the Holders’ Registrable Securities in such underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the
underwriters selected by it (or by other persons entitled to select the underwriters), and then only in such quantity as the underwriters determine, in their sole discretion, will not jeopardize the success of the offering by the Company. All
Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in subsection 1.4(e)) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for
such underwriting. If the total amount of securities, including Registrable Securities requested by stockholders to be included in such offering, exceeds the amount of securities sold other than by the Company that the underwriters determine in
their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters determine in their sole
discretion will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling stockholders according to the total amount of securities requested to be included therein by each such selling
stockholder or in such other proportions as shall mutually be agreed to by such selling stockholders), but in no event shall (i) the amount of securities of the selling Holders included in the offering be reduced unless the securities of all
other selling stockholders included in the offering are excluded entirely or (ii) the amount of securities of the selling Holders included in the offering be reduced below thirty percent (30%) of the total amount of securities included in
such offering, unless such offering is the Qualified IPO (as such term is defined in the Company’s Amended and Restated Certificate of Incorporation, as may be amended or amended or restated from time to time (the “Restated
Certificate”)), in which case such Holders may be excluded entirely if the underwriters make the determination described above and if the securities of all other selling stockholders are excluded entirely. For purposes of the preceding
parenthetical concerning apportionment, for any selling stockholder which is a Holder of Registrable Securities and which is a partnership, limited liability company or corporation, the partners (or retired partners), members (or retired members)
and stockholders of such selling stockholder, or the estates and family members of any such partners (or retired partners), members (or retired members) or stockholders and any trusts for the benefit of any of the foregoing persons shall be deemed
to be a single “selling stockholder” and any pro rata reduction with respect to such “selling stockholder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals
included in such “selling stockholder” as defined in this sentence. 
 1.9. Delay of Registration. No Holder
shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

1.10. Indemnification. 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, each of its officers, directors, partners, members, stockholders, legal counsel, and accountants and each
person controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to which registration, qualification, or compliance has been effected pursuant to this Section 1, and each underwriter, if any, and each
person who controls within the meaning of Section 15 of the Securities Act any underwriter, against all expenses, claims, losses, damages, and liabilities (or actions, proceedings, or settlements in

  
 8 

 
respect thereof) arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any prospectus, offering
circular, or other document (including any related registration statement, notification, or the like) incident to any such registration, qualification, or compliance, (ii) any omission (or alleged omission) to state therein a material fact
required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation (or alleged violation) by the Company of the Securities Act, any state securities laws or any rule or regulation thereunder
applicable to the Company and relating to action or inaction required of the Company in connection with any offering covered by such registration, qualification, or compliance, and the Company will reimburse, as incurred, each such Holder, each of
its officers, directors, partners, members, stockholders, legal counsel, and accountants and each person controlling such Holder, each such underwriter, and each person who controls any such underwriter, for any legal and any other expenses
reasonably incurred in connection with investigating and defending or settling any such claim, loss, damage, liability, or action; provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage,
liability, or action arises out of or is based on any untrue statement or omission based upon written information furnished to the Company by such Holder, such underwriter or any person who controls such underwriter and stated to be specifically for
use therein; and provided, further that, the indemnity agreement contained in this Section 1.10(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without
the consent of the Company (which consent shall not be unreasonably withheld). 
 (b) To the extent permitted by law, each
Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification, or compliance is being effected, indemnify and hold harmless the Company, each of its directors, officers, legal
counsel, and accountants and each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15 of the Securities Act,
each other such Holder, and each of their officers, directors, partners, members, stockholders, legal counsel and accountants and each person controlling such Holder, against all claims, losses, damages and liabilities (or actions in respect
thereof) arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any such registration statement, prospectus, offering circular, or other document, or
(ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company and such Holders, directors, officers, partners,
legal counsel, and accountants, underwriters, or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability, or action, in each case to the extent,
but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular, or other document in reliance upon and in conformity with
written information furnished to the Company by such Holder and stated to be specifically for use therein; provided, however, that the obligations of such Holder hereunder shall not apply to amounts paid in settlement of any such claims,
losses, damages, or liabilities (or actions in respect thereof) if such settlement is effected without the consent of such Holder (which consent shall not be unreasonably withheld); and provided that in no event shall any indemnity under this
Section 1.10(b), when combined with amounts paid under Section 1.10(d), exceed the net proceeds from the offering received by such Holder. 

  
 9 

 (c) Each party entitled to indemnification under this Section 1.10 (the
“Indemnified Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be
sought, and shall permit the Indemnifying Party to assume the defense of such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or any litigation
resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may participate in such defense at such party’s expense; provided, however, that an
Indemnified Party (together with each other Indemnified Party which may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable fees and expenses to be paid by the Indemnifying Party,
if representation of such Indemnified Party by the counsel retained by the Indemnifying Party would be inappropriate due to actual or potential differing interests between such Indemnified Party and any other party represented by such counsel in
such proceeding. The failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 1.10, to the extent such failure is not prejudicial. No Indemnifying Party,
in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant
or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. Each Indemnified Party shall furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably
request in writing and as shall be reasonably required in connection with defense of such claim and litigation resulting therefrom. 
 (d) If the indemnification provided for in this Section 1.10 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any loss, liability, claim, damage,
or expense referred to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, liability, claim, damage, or
expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or omissions that resulted in such loss, liability,
claim, damage, or expense as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information, and opportunity to
correct or prevent such statement or omission. In no event shall any Holder be required to contribute an amount, when combined with amounts paid pursuant to Section 1.10(b), in excess of the net proceeds from the offering received by such
Holder. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in
the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions of the underwriting agreement shall control. 

  
 10 

 (f) The obligations of the Company and Holders under this Section 1.10 shall survive
the completion of any offering of Registrable Securities in a registration statement under this Section 1, and otherwise. 

1.11. Reports Under Securities Exchange Act. With a view to making available the benefits of certain rules and regulations of the
Commission, including Rule 144, that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 

(a) make and keep public information available, as those terms are understood and defined in Rule 144, at all times after ninety
(90) days after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public; 
 (b) take such action, including the voluntary registration of its Common Stock under Section 12 of the Exchange Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of
their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of its securities to the general public is declared
effective; 
 (c) file with the Commission in a timely manner all reports and other documents required of the Company under the
Securities Act and the Exchange Act; and 
 (d) furnish to any Holder, so long as the Holder owns any Registrable Securities,
forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) calendar days after the effective date of the first registration statement
filed by the Company), the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after
it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder
of any rule or regulation of the Commission that permits the selling of any such securities without registration or pursuant to such form. 
 1.12. Form S-3 Registration. 
 (a) Subject to the conditions of this
Section 1.12, if the Company shall receive from the Holders of at least twenty-five percent (25%) of the Registrable Securities then outstanding a written request that the Company effect a registration on Form S-3 and any related
qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder(s), then the Company shall (i) promptly give written notice of the proposed registration, and any related qualification or compliance,
to all other Holders and (ii) use its best efforts to effect, as soon as practicable, such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or
such portion of the Registrable Securities specified in such request, together with all or such portion of the Registrable Securities of any other Holder joining in such request as are 

  
 11 

 
specified in a written request given within fifteen (15) calendar days of the date the Company’s notice referred to in clause (a) of this sentence is given. 

(b) If the Holders requesting registration pursuant to this Section 1.12 intend to distribute the Registrable Securities covered by
their request by means of an underwriting, they shall so advise the Company as part of their request made pursuant to this Section 1.12 and the Company shall include such information in the written notice referred to in clause (i) of
Section 1.12(a). The underwriter will be selected by the Company and shall be reasonably acceptable to a majority in interest of the Holders requesting registration. In such event, the right of any Holder to include such Holder’s
Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders
proposing to distribute their securities through such underwriting shall (together with the Company as provided in Section 1.4(e)) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such
underwriting. Notwithstanding any other provision of this Section 1.12, if the underwriter advises the Holders requesting registration in writing that marketing factors require a limitation of the number of shares to be underwritten, then the
Holders requesting registration shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall be
allocated among all Holders thereof, including the Holders requesting registration, in proportion (as nearly as practicable) to the amount of Registrable Securities requested by each such Holder to be included in such underwriting; provided,
however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other securities (including those to be sold for the Company’s account) are first entirely excluded from the
underwriting. For purposes of the preceding parenthetical concerning apportionment, for any selling stockholder which is a Holder of Registrable Securities and which is a partnership, limited liability company or corporation, the partners (or
retired partners), members (or retired members) and stockholders of such selling stockholder, or the estates and family members of any such partners (retired partners), members (or retired members) or stockholders and any trusts for the benefit of
any of the foregoing persons shall be deemed to be a single “selling stockholder” and any pro rata reduction with respect to such “selling stockholder” shall be based upon the aggregate amount of shares carrying registration
rights owned by all entities and individuals included in such “selling stockholder” as defined in this sentence. 

(c) Notwithstanding the foregoing, if the Company shall furnish to the Holder(s) requesting a registration pursuant to this
Section 1.12, a certificate signed by the Company’s President stating that in the good faith judgment of the Company’s Board of Directors, such registration would be seriously detrimental to the Company and its stockholders and that
it is, therefore, essential to defer taking action with respect to such registration, the Company shall have the right to defer taking action with respect to such filing for a period of not more than ninety (90) calendar days after the date the
request of the Holder(s) requesting a registration pursuant to this Section 1.12 is given; provided, however, that the Company shall not utilize this right or the right set forth in Section 1.2(c) more than once in any
twelve (12) month period; and provided, further, that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period other than a registration

  
 12 

 
relating solely to employee benefit or similar plans, or a registration relating to a Rule 145 transaction. 
 (d) In addition, the Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to this Section 1.12: 

(i) if Form S-3 is not available for such offering by the Holders; 

(ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration,
propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of underwriting discounts and commissions) of less than $1,000,000; 

(iii) if the Company has, within the twelve (12) month period preceding the date of such request, already effected three
(3) registration on Form S-3 for the Holders pursuant to this Section 1.12; 
 (iv) during the period starting
with the date thirty (30) calendar days prior to the Company’s good faith estimate of the date of filing of, and ending on a date ninety (90) calendar days after the effective date of, any registration statement pertaining to a public
offering of securities for the Company’s account; provided that the Company is actively employing its best efforts to cause such registration statement to be effective; or 

(v) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act. 

(e) All expenses incurred in connection with a registration requested pursuant to this Section 1.12 (other than underwriting
discounts and commissions which shall be borne by the selling Holders on a pro rata basis), including (without limitation) all registration, filing, qualification, printer’s fees, accounting fees, fees and disbursements of counsel for the
Company and fees and disbursements of counsel for the Holders, shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to this
Section 1.12 if the registration request is subsequently withdrawn at the request of the Holders of at least a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses on a pro
rata basis), unless the Holders of at least a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to this Section 1.12; provided further, that if at the time of such withdrawal, the Holders
have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the
Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one registration pursuant to this Section 1.12. Registrations effected pursuant to this
Section 1.12 shall not be counted as demands for registration or registrations effected pursuant to Sections 1.2 or 1.3, respectively. Registrations 

  
 13 

 
withdrawn (unless the Holders of at least a majority of the Registrable Securities request the withdrawal of such registration, elect not to pay the expenses therefor and agree to forfeit their
rights to one registration pursuant to this Section 1.12) shall not be counted as demands for registration or registrations effected pursuant to this Section 1.12. 
 1.13. Transfer or Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this Section 1 may be transferred or assigned, but only with
all related obligations, by a Holder to a transferee or assignee who (i) is a subsidiary, parent, partner, limited partner, retired partner, member, former member, affiliated venture capital fund or stockholder of a Holder, (ii) is a
Holder’s family member or trust for the benefit of an individual Holder, or (iii) after such transfer, holds at least 5% of the outstanding Registrable Securities; provided that (i) prior to such transfer or assignment, the
Company is furnished with written notice stating the name and address of such transferee or assignee and identifying the securities with respect to which such registration rights are being transferred or assigned, (ii) such transferee or
assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including without limitation the provisions of Section 1.15 and (iii) such transfer or assignment shall be effective only if immediately
following such transfer or assignment the further disposition of such securities by the transferee or assignee is restricted under the Securities Act. 
 1.14. Limitations on Subsequent Registration Rights. From and after the Effective Date, the Company shall not, without the prior written consent of (a) the Holders of at least sixty percent
(60%) of the Registrable Securities then outstanding, (b) the Holders of a majority of the Series D Stock or the Conversion Stock issued upon conversion of the Series D Stock then-outstanding and (c) the Holders of a
majority of the Series E Stock or the Conversion Stock issued upon conversion of the Series E Stock then-outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company which would allow such
holder or prospective holder (i) to include such securities in any registration upon terms that are more favorable to such holder or prospective holder than the terms on which the Holders may include shares in such registration or (ii) to
make a demand registration. 
 1.15. “Market Stand-Off” Agreement. Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the initial public offering by the Company and ending on the date specified by the Company and the managing
underwriter (such period not to exceed one hundred eighty (180) calendar days or such longer period, not to exceed thirty-four (34) calendar days after the expiration of such 180-day period, as the Company or such managing underwriter
shall request in order to facilitate compliance with FINRA rules) (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
or otherwise transfer or dispose of, directly or indirectly, any securities of the Company, including (without limitation) shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether now owned
or hereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any securities of the Company, including (without limitation) shares of
Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether now owned or hereafter acquired), whether any such transaction described in clause 

  
 14 

 
(i) or (ii) above is to be settled by delivery of securities, in cash or otherwise. The foregoing covenants shall not apply to the sale of any shares by a Holder to an underwriter
pursuant to an underwriting agreement or to shares purchased by a Holder in the open market following the completion of the initial public offering, and shall only be applicable to the Holders if all the Company’s executive officers, directors
and greater than five percent (5%) stockholders enter into similar agreements. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders
subject to such agreements, based on the number of shares subject to such agreements. Each Holder agrees to execute an agreement(s) reflecting (i) and (ii) above as may be requested by the managing underwriters at the time of the
initial public offering, and further agrees that the Company may impose stop transfer instructions with its transfer agent in order to enforce the covenants in (i) and (ii) above. The underwriters in connection with the Company’s
initial public offering are intended third party beneficiaries of the covenants in this Section 1.15 and shall have the right, power and authority to enforce such covenants as though they were a party hereto. 

1.16. Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for in this Section 1
after the earlier of (i) six (6) years following the consummation of the sale of securities pursuant to a registration statement filed by the Company under the Securities Act in connection with the Qualified IPO or (ii) as to any
Holder, such time, on or after the closing of the Company’s first registered public offering of Common Stock, at which all Registrable Securities held by such Holder can be sold free of restrictions and without registration in compliance with
Rule 144 of the Securities Act. 
 2. Covenants of the Company to the Investors. 

2.1. Information Rights. The Company shall deliver to each Investor who holds (and continues to hold) either (i) at least 5%
of Conversion Stock or (ii) Conversion Stock having an aggregate preferential amount payable upon a Liquidation Event (as defined in the Restated Certificate) of at least $15,000,000 (each a “Major Investor”): 

(a) as soon as practicable, but in any event within one hundred twenty (120) calendar days after the end of each fiscal year of the
Company, consolidated balance sheets of the Company and its subsidiaries, if any, as of the end of such fiscal year, and consolidated statements of income and consolidated statements of cash flows of the Company and its subsidiaries, if any, for
such year, prepared in accordance with generally accepted accounting principles (“GAAP”), all in reasonable detail and audited by independent public accountants of national standing selected by the Company; 

(b) as soon as practicable, but in any event within forty-five (45) calendar days after the end of each of the first three
(3) quarters of each fiscal year of the Company, consolidated balance sheets of the Company and its subsidiaries, if any, as of the end of such quarter, and consolidated statements of income and consolidated statements of cash flows of the
Company and its subsidiaries, if any, for such quarter prepared in accordance with GAAP, all in reasonable detail; 
 (c) as
soon as practicable, but in any event within thirty (30) calendar days of the end of each month, consolidated balance sheets of the Company and its subsidiaries, 

  
 15 

 
if any, as of the end of such month, and consolidated statements of income and consolidated statements of cash flows of the Company and its subsidiaries, if any, for such month prepared in
accordance with GAAP, all in reasonable detail; 
 (d) as soon as practicable, but in any event within thirty (30) calendar
days of the end of each month, executive summaries of the Company’s principal activities; and 
 (e) as soon as
practicable, but in any event within forty-five (45) calendar days prior to the end of each fiscal year, a budget and business plan for the next fiscal year, prepared on a monthly basis, including balance sheets and income statements for such
months and, as soon as prepared, any other budgets or revised budgets prepared by the Company. 
 2.2. Visitation and
Inspection. The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances
and accounts with its officers, all at such reasonable times as may be requested by such Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 2.2 to provide access to any information that it
reasonably considers in good faith to be a trade secret or similar confidential information. The provisions of this Section 2.2 shall not be in limitation of any rights which any Investor may have with respect to the books and records of the
Company and its subsidiaries, or to inspect their properties or discuss their affairs, finances and accounts, under the laws of the State of Delaware. 
 2.3. Right of First Offer. Subject to the terms and conditions specified in this Section 2.3, the Company hereby grants to each Investor (including any other party to which the rights set
forth in this Section 2.3 have been assigned or transferred in accordance with Section 2.6(b)) (each, an “Offeree”), a right of first offer to subscribe for and purchase such Offeree’s Pro Rata Share (as hereinafter
defined for the purpose of this Section 2.3), in whole or in part, of future issuances by the Company of Future Shares (as hereinafter defined). Each Offeree shall be entitled to assign or apportion the right of first offer among its partners
and affiliates (including, in the case of a venture capital fund, other venture capital funds affiliated with such fund) in such proportions as it deems appropriate. For purposes of this Section 2.3, an Offeree’s “Pro Rata
Share” of Future Shares shall be a fraction, the numerator of which is the number of shares of Common Stock held, or issuable upon conversion of the Preferred Stock held by such Offeree immediately prior to the issuance of Future Shares and
the denominator of which is the total number of shares of the Company’s Common Stock outstanding (assuming full conversion of all outstanding Preferred Stock) immediately prior to the issuance of Future Shares. Each time the Company proposes to
offer any shares of, or securities convertible into or exercisable for any shares of, any class of its capital stock (“Future Shares”), the Company shall first make an offering of such Future Shares to each Offeree in accordance
with the following provisions: 
 (a) The Company shall deliver a notice (“Notice”) to each Offeree stating
(i) the Company’s bona fide intention to offer such Future Shares, (ii) the number of such Future Shares to be offered, and (iii) the price and a summary of the terms, if any, upon which it proposes to offer such Future Shares.

  
 16 

 (b) Each Offeree may elect to subscribe for and purchase, at the price and on the terms
specified in the Notice, (i) up to such Offeree’s Pro Rata Share of the Future Shares and (ii) such additional number of the Future Shares as such Offeree indicates it is willing to purchase should the other Offerees subscribe for
less than their respective Pro Rata Shares (for each Offeree, the “Additional Portion”) by notifying the Company in writing within fifteen (15) calendar days from the date the Notice is given by the Company. 

(c) If the aggregate number of Future Shares subscribed for pursuant to subsection (b) above is less than the aggregate Pro Rata
Share for which all Offerees are entitled to subscribe, then each Offeree who has subscribed for an Additional Portion pursuant to subsection (b) above shall be entitled to purchase, in addition to such Offeree’s Pro Rata Share, the
Additional Portion subscribed for by such Offeree; provided, however, that if the Additional Portions subscribed for by all Offerees exceed the difference obtained by subtracting (x) the aggregate Pro Rata Share for which all Offerees
are entitled to subscribe from (y) the number of Future Shares subscribed for by all Offerees (the “Available Additional Portion”), then each Offeree who has subscribed for an Additional Portion shall be entitled to purchase
only that portion of the Available Additional Portion as such Offeree’s Pro Rata Share bears to the aggregate Pro Rata Share for all Offerees who subscribed for an Additional Portion, subject to rounding by the Company’s Board of Directors
to the extent it reasonably deems necessary and equitable. To the extent that Future Shares are not purchased by the Offerees as provided in subsection (b) above and this subsection (c), the Company may, during the ninety (90) calendar
days following the expiration of the period provided in subsection (b) above, offer the remaining unsubscribed portion of such Future Shares to any person or persons at a price not less than and upon terms no more favorable than those specified
in the Notice. If the Company does not enter into an agreement for the sale of the Future Shares within such period, or if such agreement is not consummated within thirty (30) calendar days of the execution thereof, the right provided in this
Section 2.3 shall be deemed to be revived and such Future Shares shall not be offered unless first reoffered to the Offerees in accordance herewith. 
 (d) The right of first offer in this Section 2.3 shall not be applicable to (i) the Series F Stock sold pursuant to the Series F Agreement; (ii) the Conversion Stock;
(iii) securities issued in connection with any dividend, distribution, combination or subdivision with respect to the Common Stock or the Preferred Stock; (iv) securities issued to the Company’s employees, officers, directors,
consultants, advisors or service providers for the primary purpose of soliciting or retaining their services or for charitable purposes pursuant to any plan, agreement or similar arrangement approved by the Company’s Board of Directors,
including a majority of the Preferred Directors (as such term is defined in the Restated Certificate); (v) securities issued in connection with obtaining lease financing, whether issued to a lender, lessor, guarantor or other provider of goods
and services to the Company in a transaction entered into for primarily non-equity financing purposes and approved by the Company’s Board of Directors, including a majority of the Preferred Directors; (vi) securities issued in connection
with strategic transactions involving the Company and other entities not primarily for the financing purposes, including (a) joint ventures, manufacturing, marketing or distribution arrangements or (b) technology transfer or development
arrangements; provided that such strategic transactions and the issuance of shares therein, have been approved by the Company’s Board of Directors, including a majority of the Preferred Directors; (vii) securities issued in a firm
commitment underwritten public offering pursuant to an effective registration 

  
 17 

 
statement under the Securities Act pursuant to which all outstanding shares of each series of Preferred Stock are converted to Common Stock; (viii) securities issued in connection with a
bona fide business acquisition of or by the Company (whether by merger, consolidation, sale of assets, sale or exchange of stock or otherwise), provided such acquisition is approved by the Company’s Board of Directors, including a majority of
the Preferred Directors; (ix) securities issued upon exercise or conversion of any warrants outstanding as of the Effective Date; or (xii) up to $1,000,000 of securities (in the aggregate) issued to Triple Point Capital and Pinnacle
Ventures or their affiliates pursuant to rights granted in connection with a credit facility between the Company and such lenders. 
 2.4. Other Covenants. 
 (a) Proprietary Information and Inventions
Assignment Agreement. The Company will cause each person now or hereafter employed by it or any subsidiary with access to confidential information to enter into a proprietary information and inventions assignment agreement in the form approved
by the Company’s counsel. 
 (b) Employee and Other Stock Arrangements. Each acquisition of any
shares of the Company’s capital stock or any option or right to acquire any shares of the Company’s capital stock by an employee, consultant, officer or director of the Company will be conditioned upon the execution and delivery by the
Company and such employee, consultant, officer or director of an agreement substantially in the form approved by the Board of Directors. Unless otherwise determined by the Board of Directors, any such option or right to acquire shares of the
Company’s capital stock shall vest at the rate of one-fourth ( 1/4th) of the shares granted after one year from the date of grant and one forty-eighth (1/48th) of the total number of shares granted monthly thereafter.
Unless otherwise determined by the Company’s Board of Directors, any stock sold shall be subject to the Company’s right to repurchase such stock at its original purchase price and such stock shall vest on the same schedule as set forth in
the preceding sentence. 
 (c) Directors and Officers Insurance. The Company will use its commercially reasonable
efforts to cause to be maintained from financially sound and reputable insurers directors and officers insurance with coverage customary for companies similarly situated to the Company, except as otherwise decided in accordance with policies adopted
by the Company’s Board of Directors. Such policy shall not be cancelable by the Company without prior approval of the Board of Directors. 
 (d) Liability Insurance. The Company will use its commercially reasonable efforts to cause to be maintained from financially sound and reputable insurers general liability insurance in amounts
customary for companies similarly situated, except as otherwise decided in accordance with policies adopted by the Company’s Board of Directors. Such policy shall name the Company as loss payee and shall not be cancelable by the Company without
prior approval of the Board of Directors. 
 (e) Special Relationships. The Company shall not, without the unanimous
approval of the Company’s Board of Directors, offer employment as a vice president, 

  
 18 

 
executive officer or other key employee of the Company to any family member of a then current employee of the Company. 
 (f) Financial Controls. The Company shall adhere to the internal financial controls established by the audit committee of the Company’s Board of Directors (the “Audit
Committee”) during the Audit Committee meeting held on November 3, 2008. The Audit Committee shall keep the Company’s Board of Directors apprised of any developments with respect to such financial controls and shall continue to
make recommendations to the Company’s Board of Directors with respect thereto. 
 2.5. Observer Rights. A
representative designated in writing by the holders of a majority of the outstanding shares of Series E Preferred Stock (the “Board Observer”) shall have the right to attend, in a nonvoting observer capacity, all meetings of
the Company’s Board of Directors at which the Series E Director (as defined in that certain Amended and Restated Voting Agreement dated as of even date herewith by and among the Company and certain of its stockholders (as such agreement
may be amended from time to time, the “Voting Agreement”) does not attend (whether in person, by teleconference or any other means permitted by the Company’s Bylaws and/or the Delaware General Corporation Law) or any part
thereof, and, in this respect, the Company shall give the Board Observer copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that the Board Observer shall agree to hold in confidence
and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude the Board Observer from any meeting or portion thereof if
access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. 

2.6. Confidentiality, Assignment and Termination of Covenants. 

(a) Confidentiality. Each Investor receiving information under the covenants set forth in Sections 2.1 and 2.2 hereby agrees to
hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; provided, however, that notwithstanding the foregoing, an Investor (1) may include summary financial information concerning the Company
and general statements concerning the nature and progress of the Company’s business in an Investor’s reports to its limited partners, (2) may disclose information to its directors, officers, partners, members, stockholders, employees,
agents and advisors who have a need to know such information and (3) may disclose information to the extent required by applicable law, regulation or legal process. 
 (b) Assignment. The covenants set forth in Sections 2.1, 2.2 and 2.3 may be assigned or transferred, but only with all related obligations, by an Investor to an assignee or transferee who
(i) is a subsidiary, parent, partner, limited partner, retired partner, member, former member, affiliated venture capital fund or stockholder of a Holder, (ii) is a Holder’s family member or trust for the benefit of an individual
Holder, (iii) holds or acquires at least 5% of the Conversion Stock then outstanding or (iv) is an Investor listed on SCHEDULE A hereto. 

  
 19 

 (c) Termination. The covenants set forth in Sections 2.1, 2.2, 2.3, 2.4 and 2.5 shall
terminate as to all Investors and be of no further force or effect upon the earlier to occur of (i) the closing of a Qualified IPO (as such term is defined in the Restated Certificate) or (ii) the closing of a Change of Control (as such
term is defined in the Restated Certificate). The covenants set forth in Sections 2.1 and 2.2 shall also terminate as to all Investors and be of no further force or effect upon the date upon which the Company first becomes subject to the periodic
reporting requirements of Sections 12(g) or 15(d) of the Exchange Act. 
 3. Investment Activities. The Company
acknowledges that certain of the Investors and their affiliates, members, equity holders, director representatives, partners, employees, agents and other related persons are engaged in the business of investing in private and public companies in a
wide range of industries, including the industry segment in which the Company operates (the “Company Industry Segment”). Accordingly, the Company and the Investors acknowledge and agree that a Covered Person shall: 

(a) have no duty to the Company to refrain from participating as a director, investor or otherwise with respect to any company or other
person or entity that is engaged in the Company Industry Segment or is otherwise competitive with the Company, and 
 (b) in
connection with making investment decisions, to the fullest extent permitted by law, have no obligation of confidentiality or other duty to the Company to refrain from using any information, including, but not limited to, market trend and market
data, which comes into such Covered Person’s possession, whether as a director, investor or otherwise (the “Information Waiver”), provided that the Information Waiver shall not apply, and therefore such Covered Person shall be subject
to such obligations and duties as would otherwise apply to such Covered Person under applicable law, if the information at issue (i) constitutes material non-public information concerning the Company, or (ii) is covered by a contractual
obligation of confidentiality to which the Company is subject. 
 Notwithstanding anything in this Section 3 to the
contrary, nothing herein shall be construed as a waiver of any Covered Person’s duty of loyalty or obligation of confidentiality with respect to the disclosure of confidential information of the Company. 

For the purposes of this Section 3, “Covered Persons” shall have the meaning set forth in the Restated Certificate.

 Notwithstanding clause (a) of this Section 3, if a Covered Person serving as a director of the Company is or
becomes a director of an entity whose business is competitive with the Company’s business, such Covered Person shall so notify the Company promptly and, upon the Company’s request, will resign as a director of the Company (it being
understood that any such resignation shall not limit an Investor’s right to designate another individual to serve on the Company’s Board of Directors, to the extent an Investor has the right to do so under the Voting Agreement).

  
 20 

 4. Legend. Each certificate representing the shares of Common Stock and/or Preferred
Stock held by the Investors shall be endorsed with the following legend (the “Legend”): 
 THE SHARES REPRESENTED BY
THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD OF UP TO 180 DAYS FOLLOWING THE EFFECTIVE DATE OF A REGISTRATION STATEMENT OF THE COMPANY FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN THAT CERTAIN AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT BETWEEN THE CORPORATION AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE CORPORATION’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 

The Company agrees that, during the term of this Agreement, it will not remove, and will not permit to be removed (upon registration of
transfer, reissuance or otherwise), the Legend from any such certificate and will place or cause to be placed the Legend on any new certificate theretofore represented by a certificate carrying the Legend. 

5. Miscellaneous. 
 5.1. Governing Law. This Agreement shall be governed in all respects by the laws of the state of California as such laws are applied to agreements between California residents entered into and to
be performed entirely within California, without regard to conflict of laws rules. 
 5.2. Waiver of Right of First
Offer. Each Prior Investor holding a right of first offer to purchase new securities of the Company pursuant to Section 2.3 of the Series E Rights Agreement by its execution of this Agreement, hereby waives any rights it may have
pursuant to such section to purchase shares of Series F Stock (and any related or corresponding notice requirements) beyond that number of shares such Prior Investor is purchasing under the Series F Agreement and, further, confirms that such
Prior Investor has no rights to purchase securities of the Company in the future except as set forth in Section 2.3 hereof or except as set forth in warrants to purchase capital stock held by such Prior Investor. 

5.3. Waivers and Amendments. This Agreement may be terminated with the written consent of (i) the Company, (ii) the
Investors holding at least sixty percent (60%) of the Registrable Securities then outstanding (the “Majority Investors”), (iii) the Investors holding a majority of the Series D Stock or Conversion Stock issued upon
conversion of the Series D Stock then held by all Investors, and (iv) the Investors holding a majority of the Series E Stock or Conversion Stock issued upon conversion of the Series E Stock then held by all Investors. Any term of
this Agreement may be amended or waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of the Company and the Majority Investors. Notwithstanding the foregoing,
(i) this Agreement may not be amended, and 

  
 21 

 
no provision hereof may be waived, in each case, in any way which would adversely affect the rights and obligations hereunder of the Investors holding Series D Stock or Conversion Stock
issued upon conversion of the Series D Stock with respect to such shares without also the written consent of the Investors holding a majority of the Series D Stock or the Conversion Stock issued upon conversion of the Series D Stock
then-held by all Investors, and (ii) this Agreement may not be amended, and no provision hereof may be waived, in each case, in any way which would adversely affect the rights and obligations hereunder of the Investors holding Series E
Stock or Conversion Stock issued upon conversion of the Series E Stock with respect to such shares without also the written consent of the Investors holding a majority of the Series E Stock or the Conversion Stock issued upon conversion of
the Series E Stock then-held by all Investors. Any termination, amendment or waiver effected in accordance with this Section 5.3 shall be binding upon each holder of Registrable Securities then outstanding, each future holder of all such
Registrable Securities and the Company. In the event of a subsequent closing with an investor as provided for in Section 1.3 of the Series F Agreement, such investor shall become a party to this Agreement as an “Investor” upon
the Company’s receipt from such investor of an executed counterpart signature page to this Agreement. 
 5.4. Successors
and Assigns. Except as otherwise expressly provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

5.5. Entire Agreement. This Agreement constitutes the full and entire understanding and agreement among the parties with regard to
the subject matter hereof, and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth herein. 

5.6. Notices. All notices and other communications required or permitted under this Agreement shall be in writing and shall be
delivered personally by hand or by courier, sent by overnight delivery, mailed by United States first-class mail, postage prepaid, sent by facsimile or sent by electronic mail directed (a) if to an Investor, at such Investor’s address,
facsimile number or electronic mail address set forth in the Company’s records, or at such other address, facsimile number or electronic mail address as such Investor may designate by ten (10) days’ advance written notice to the other
parties hereto or (b) if to the Company, to its address, facsimile number or electronic mail address set forth on its signature page to this Agreement and directed to the attention of the President, or at such other address, facsimile number or
electronic mail address as the Company may designate by ten (10) days’ advance written notice to the other parties hereto. All such notices and other communications shall be effective or deemed given upon personal delivery, one
(1) day after sent by overnight delivery, three (3) days after the date of mailing, upon confirmation of facsimile transfer or upon confirmation of electronic mail delivery. 

5.7. Interpretation. The words “include,” “includes” and “including” when used herein shall be
deemed in each case to be followed by the words “without limitation.” The titles and subtitles used in this Agreement are used for convenience only and are not considered in construing or interpreting this Agreement. 

  
 22 

 5.8. Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision shall be excluded from this Agreement, and the balance of the Agreement shall be interpreted as if such provision were so excluded, and shall be enforceable in accordance with its terms. 

5.9. Aggregation of Stock. All shares of Registrable Securities held or acquired by a Holder and its affiliated entities shall be
aggregated together for the purpose of determining the availability of any rights under this Agreement. For purposes of the foregoing, any shares of Registrable Securities held by a Holder that (x) is a partnership, limited liability company or
corporation shall be deemed to include shares held by (i) entities affiliated with such partnership, limited liability company or corporation, (ii) any partner (or retired partner), member (or retired member) or stockholder of such
partnership, limited liability company or corporation, (iii) the spouse, siblings, lineal descendants or ancestors of any such partner (or retired partner), member (or retired member) or stockholder, (iv) the estate of any such partner (or
retired partner), member (or retired member) or stockholder and (v) any custodian or trustee for the benefit of any such partner (or retired partner), member (or retired member) or stockholder or the spouse, siblings, lineal descendants or
ancestors of any such partner (or retired partner), member (or retired member) or stockholder and (y) is an individual shall be deemed to include shares held by (i) the estate of such individual or (ii) the spouse, siblings, lineal
descendants or ancestors of such individual and any custodian or trustee for the benefit of any of the foregoing persons. 

5.10. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of
which together shall constitute one instrument. 
 5.11. Telecopy Execution and Delivery. A facsimile, telecopy or other
reproduction of this Agreement may be executed by one or more parties hereto, and an executed copy of this Agreement may be delivered by one or more parties hereto by facsimile or similar electronic transmission device pursuant to which the
signature of or on behalf of such party can be seen, and such execution and delivery shall be considered valid, binding and effective for all purposes. At the request of any party hereto, all parties hereto agree to execute an original of this
Agreement as well as any facsimile, telecopy or other reproduction hereof. 
 5.12. Delay or Omission. Except as
expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to any Investor, upon any breach or default of the Company under this Agreement, shall impair any such right, power or remedy of such Investor nor shall
it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or
default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Investor of any breach or default under this Agreement, or any waiver on the part of any Investor of any provisions or
conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any Investor, shall be cumulative and not
alternative. 

  
 23 

 5.13. Specific Performance. It is agreed and understood that monetary damages would
not adequately compensate an injured party for the breach of this Agreement by any party, that this Agreement shall be specifically enforceable, and that any breach or threatened breach of this Agreement shall be the proper subject of a temporary or
permanent injunction or restraining order. Further, each party hereto waives any claim or defense that there is an adequate remedy at law for such breach or threatened breach. 
 5.14. Termination of Series E Rights Agreement. Pursuant to Section 5.3 of the Series E Rights Agreement, the Company, the Majority Investors (as defined in the Series E Rights
Agreement), the Prior Investors holding a majority of the Series D Stock or Conversion Stock issued upon conversion of the Series D Stock held by all Prior Investors and the Prior Investors holding a majority of the Series E Stock or
Conversion Stock issued upon conversion of the Series E Stock held by all Prior Investors, by their signatures to this Agreement, hereby agree to amend and restate the Series E Rights Agreement in its entirety such that the provisions of
this Agreement shall amend and replace in their entirety the provisions of the Series E Rights Agreement, and the provisions of the Series E Rights Agreement shall have no further force and effect, in each case, as of the Effective Date.

 [Remainder of Page Intentionally Left Blank; Signature Page Follows] 

  
 24 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“COMPANY”
	
	CHEGG, INC.
		
	By:	 	 /s/ Andrew Brown

		 	Andrew Brown,
		 	Chief Financial Officer

  

			
	Address:
		
	Street Address:	 	 2350 Mission College Blvd,
 Ste 1400

	City, State, ZIP:  	 	Santa Clara, CA 95054
	Facsimile:	 	408-855-5972
	Email:	 	legal@chegg.com

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	KPCB HOLDINGS, INC., AS NOMINEE
		
	By:	 	 /s/ Ted Schlein

	Name:	 	Ted Schlein
	Its:	 	Senior Vice President

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

					
	“INVESTORS”
	
	INSIGHT VENTURE PARTNERS VI, L.P.
		 	By:	 	 Insight Venture Associates VI, L.P.,
 its general partner

		 	By:	 	 Insight VI GP, LLC,
 its
general partner

		
	By:	 	 /s/ Blair M. Flicker

		 	Name:	 	Blair M. Flicker
		 	Title:	 	Attorney-in-Fact
	
	INSIGHT VENTURE PARTNERS (CO-INVESTORS), L.P.
		 	By:	 	 Insight Venture Associates VI, L.P.,
 its general partner

		 	By:	 	 Insight VI GP, LLC,
 its
general partner

		
	By:	 	 /s/ Blair M. Flicker

		 	Name:	 	Blair M. Flicker
		 	Title:	 	Attorney-in-Fact
	
	INSIGHT VENTURE PARTNERS VI (CAYMAN), L.P.
		 	By:	 	 Insight Venture Associates VI, L.P.,
 its general partner

		 	By:	 	 Insight VI GP, LLC,
 its
general partner

		
	By:	 	 /s/ Blair M. Flicker

		 	Name:	 	Blair M. Flicker
		 	Title:	 	Attorney-in-Fact

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	ACE LIMITED
		
	By:	 	 /s/ Lim Beng Jin

		
	Name:	 	 Lim Beng Jin

		
	Title:	 	 Director

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	MOOS LLC
		
	By:	 	 /s/ Oren Zeev

	Its:	 	 Oren Zeev

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	GABRIEL VENTURE PARTNERS II, L.P.
	By:	 	Gabriel Investment Partners II, L.P.,
	Its General Partner
		
	By:	 	 /s/ Frederick W. W. Bolander

		 	Frederick W.W. Bolander, General Partner
	
	GABRIEL LEGACY FUND II, L.P.
	By:	 	Gabriel Investment Partners II, L.P.,
	Its General Partner
		
	By:	 	 /s/ Frederick W. W. Bolander

		 	Frederick W.W. Bolander, General Partner

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	FOUNDATION CAPITAL VI, LP
	By:	 	Foundation Capital Management Co. VI, LLC
		
	By:	 	 /s/ Paul Holland

		 	Manager
	
	FOUNDATION CAPITAL VI PRINCIPALS FUND, LLC
		
	By:	 	Foundation Capital Management Co. VI, LLC
		
	By:	 	 /s/ Paul Holland

		 	Manager

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

							
		 		 	“INVESTORS”
			
		 		 	 Gothic Corporation

		 		 	(Name of Investor)
			
	 /s/ David R. Shumate
	 		 	 /s/ Edward P. Hutchinson

	David R. Shumate	 		 	(Signature of Investor or authorized signatory)
	Executive Vice President	 		 		 	
	DUMAC, LLC	 		 	 Edward P. Hutchinson

	Authorized Agent	 		 	(Print name of Investor or authorized signatory)
			
		 		 	 Investment Manager, DUMAC, LLC, Authorized Agent

		 		 	(If signing as an authorized signatory, print your title)
			
		 		 	Address:
		 		 	 DUMAC

		 		 	 280 South Mangum Street, Suite 210

		 		 	 Durham, NC 27701-3675

		 		 	Telephone:	 	 919-668-9995

		 		 	Facsimile:	 	 919-668-9926

		 		 	E-mail:	 	 investments@dumac.duke.edu

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year first set forth
above. 
  

							
	 	 	 	 	“INVESTORS”
			
		 		 	 Gothic ERP LLC

		 		 	(Name of Investor)
			
	 /s/ David R. Shumate
	 	 	 	 /s/ Edward P. Hutchinson

	David R. Shumate	 		 	(Signature of Investor or authorized signatory)
	Executive Vice President	 		 		 	
	DUMAC, LLC	 		 	 Edward P. Hutchinson

	Authorized Agent	 		 	(Print name of Investor or authorized signatory)
			
	 	 	 	 	 Investment Manager, DUMAC, LLC, Authorized Agent

		 		 	(If signing as an authorized signatory, print your title)
			
		 		 	Address:
		 		 	 DUMAC

		 		 	 280 South Mangum Street, Suite 210

		 		 	 Durham, NC 27701-3675

		 		 	Telephone:	 	 919-668-9995

		 		 	Facsimile:	 	 919-668-9926

		 		 	E-mail:	 	 investments@dumac.duke.edu

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year first set forth
above. 
  

							
		 		 	“INVESTORS”
			
		 		 	 The Duke Endowment

		 		 	(Name of Investor)
			
	 /s/ David R. Shumate
	 		 	 /s/ Edward P. Hutchinson

	David R. Shumate	 		 	(Signature of Investor or authorized signatory)
	Executive Vice President	 		 		 	
	DUMAC, LLC	 		 	 Edward P. Hutchinson

	Authorized Agent	 		 	(Print name of Investor or authorized signatory)
			
		 		 	 Investment Manager, DUMAC, LLC, Authorized Agent

		 		 	(If signing as an authorized signatory, print your title)
			
		 		 	Address:
		 		 	 DUMAC

		 		 	 280 South Mangum Street, Suite 210

		 		 	 Durham, NC 27701-3675

		 		 	Telephone:	 	 919-668-9995

		 		 	Facsimile:	 	 919-668-9926

		 		 	E-mail:	 	 investments@dumac.duke.edu

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year first set forth
above. 
  

							
		 		 	“INVESTORS”
			
		 		 	 Gothic HSP Corporation

		 		 	(Name of Investor)
			
	 /s/ David R. Shumate
	 		 	 /s/ Edward P. Hutchinson

	David R. Shumate	 		 	(Signature of Investor or authorized signatory)
	Executive Vice President	 		 		 	
	DUMAC, LLC	 		 	 Edward P. Hutchinson

	Authorized Agent	 		 	(Print name of Investor or authorized signatory)
			
		 		 	 Investment Manager, DUMAC, LLC, Authorized Agent

		 		 	(If signing as an authorized signatory, print your title)
			
		 		 	Address:
		 		 	 DUMAC

		 		 	 280 South Mangum Street, Suite 210

		 		 	 Durham, NC 27701-3675

		 		 	Telephone:	 	 919-668-9995

		 		 	Facsimile:	 	 919-668-9926

		 		 	E-mail:	 	 investments@dumac.duke.edu

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	 The Burgess Family Trust dated July 22, 1998

	(Name of Investor)
	
	 /s/ Robert K. Burgess

	(Signature of Investor or authorized signatory)
	
	 Robert K. Burgess

	(Print name of Investor or authorized signatory)
	
	 Trustee

	(If signing as an authorized signatory, print your title)
	
	Address:
	 Dpt 3 c/o Harris myCFO, Inc.

	 P.O. Box 10195

	 Palo Alto, CA 94303

	Telephone:	 	 650-210-5128

	Facsimile:	 	 650-210-5250

	E-mail:	 	 bur001fos@mycfo.com

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	 Lucas Venture Group III, LP

	(Name of Investor)
	
	 /s/ Donald A. Lucas

	(Signature of Investor or authorized signatory)
	
	 Donald A. Lucas

	(Print name of Investor or authorized signatory)
	
	 Managing Member

	(If signing as an authorized signatory, print your title)
	
	Address:
	 545 Middlefield Road, Suite 220

	 Menlo Park, CA 94025

	  

	Telephone:	 	 (650) 543-3300

	Facsimile:	 	 (650) 543-3339

	E-mail:	 	 don@lucasvg.com

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year first set forth
above. 
  

			
	“INVESTORS”
	
	 Lucas Venture Group VIII, LLC

	(Name of Investor)
	
	 /s/ Donald A. Lucas

	(Signature of Investor or authorized signatory)
	
	 Donald A. Lucas

	(Print name of Investor or authorized signatory)
	
	 Managing Member

	(If signing as an authorized signatory, print your title)
		
	Address:	 	
	 545 Middlefield Road, Suite 220

	 Menlo Park, CA 94025

	  

	Telephone:	 	 (650) 543-3300

	Facsimile:	 	 (650) 543-3339

	E-mail:	 	 don@lucasvg.com

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month and year
first set forth above. 
  

			
	“INVESTORS”
	
	 GSV Capital Corp.

	(Name of Investor)
	
	 /s/ Dave D. Lapping

	(Signature of Investor or authorized signatory)
	
	 Dave D. Lapping

	(Print name of Investor or authorized signatory)
	
	 COO

	(If signing as an authorized signatory, print your title)
	
	Address:
	 GSV Capital Corp.

	 2965 Woodside Road

	 Woodside, CA 94062

	Telephone:	 	 (650) 206-2165

	Facsimile:	 	 (650) 294-4783

	E-mail:	 	 dlapping@gsvam.com

 PLEASE PROVIDE ALL OF THE ABOVE-REQUESTED INFORMATION 

  
 CHEGG,
INC. 
 SIGNATURE PAGE 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 SCHEDULE A 

SCHEDULE OF INVESTORS 

Ace Limited 
 Insight Venture Partners VI, L.P.

 Insight Venture Partners VI (Co-Investors), L.P. 
 Insight Venture Partners (Cayman) VI, L.P. 
 Amit Patel 

Charles Schwab, Inc. for the benefit of Samuel T. Spadafora IRA 
 David M. Straus 
 Donald J. Morrison 
 Donald Katz 
 Eric Di Benedetto 
 Foundation Capital VI, LP 
 Foundation Capital VI Principals Fund, LLC 

Gabriel Legacy Fund II, L.P. 
 Gabriel Venture
Partners II, L.P. 
 Greg Schroeder 

Kapil K. Nanda 
 KPCB Holdings, Inc., as
nominee 
 Larry Porter 
 Maples
Investments, L.P. 
 Millennium Technology Value Partners II, L.P. 
 Millennium Technology Value Partners II-A, L.P. 
 MJMJR Ltd. 

Mohammad Osman Rashid 

  
 S-1

 MOOS LLC 
 Naren & Vimta Gupta Living Trust dtd 12/2/94 
 Philipe White and Cindie White TTEES White
Family Trust 
 Pierre Latecoere 

Robert W. Wilmot & Mary J. Wilmot, Trustees of The Wilmot Living Trust u/d/t dated April 18th 1995 

Saints Capital VI, L.P. 
 Samuel T. &
Cheryl M. Spadafora 1992 Family Trust 
 Samuel T. Spadafora 
 Shea Ventures Opportunity Fund, LP 
 Shea Ventures Opportunity Fund A-I, LLC 

Vaish Trust dated November 26, 1990 

Pinnacle Ventures II-A, L.P. 
 Pinnacle
Ventures II-B, L.P. 
 Pinnacle Ventures II-C, L.P. 
 Pinnacle Ventures II-R, L.P. 
 Pinnacle Ventures Debt Fund III-A, L.P. 

Pinnacle Ventures Debt Fund III, L.P. 

Pinnacle Ventures Equity Fund II, L.P. 

Pinnacle Ventures Equity Fund II-O, L.P. 

Triplepoint Capital LLC 
 Gothic Corporation

 Gothic ERP LLC 
 The Duke Endowment

 Gothic HSP Corporation 

  
 S-2

 Lucas Venture Group III, LP 
 Lucas Venture Group VIII, LLC 
 Motive Science LLC 

GSV Capital Corp. 
 Burgess Family Trust dated
July 22, 1998 

  
 S-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]